Page 81 - Bio Engineering Approaches to Cancer Diagnosis and Treatment
P. 81

4.3 Radio immunotherapy (RIT)      79




                  4.2.4  Clinical examinations
                  Norton et al. compared the use of chemotherapy and chemotherapy associated with
                  trastuzumab as a treatment for her2-positive breast cancer patients. By examining
                  the serum of patients before and after treatment, they observed that before treatment,
                  all patients had the same mean anti-HER2 IgG levels; but after treatment, the mean
                  levels of antibodies in the group receiving chemotherapy with trastuzumab has been
                  significantly higher. Whereas in the group that has just been chemotherapy, there has
                  been no change in the level of antibodies [24].
                     In the other clinical research Chari et al. have evaluated safety and tolerability
                  of daratumumab in combination with pomalidomide/dexamethasone (pom-dex) in
                  patients with multiple myeloma. They have found that compared to other therapies,
                  as with the use of pom-dex alone and without combining whit daratumumab, there
                  is no significant increase in the rate of infection, despite the high rate of neutropenia
                  seen. They also found that the use of daratumumab together with pom-dex induces
                  rapid, perdurable and definite response in patients who received this treatment [25].




                  4.3  Radio immunotherapy (RIT)
                  4.3.1  Radiotherapy
                  Radiotherapy is one of the major therapies for cancer treatment. Radiation therapy
                  or oncology radiation is the use of ionized rays (these rays are ionized by passage of
                  matter and produce positive and negative ions in the material) as an agent for treat-
                  ing cancer and controlling or killing malignant cells. Radiotherapy can treat some
                  of cancers that limited to part of the body. It can also be treated as part of the treat-
                  ment and prevent tumor recurrence after surgery by removing malignant tumors,
                  for example, prostate carcinomas, cervix carcinomas, lung carcinomas (nonsmall
                  cell) and lymphomas (Hodgkin’s and low grade non-Hodgkin’s) are considered to
                  be cancers that can be treated with radiotherapy alone. And breast carcinomas, rectal
                  and anal carcinomas, advanced lymphomas and CNS tumors are among the many
                  cancers that are curable with radiotherapy in combination with other treatment such
                  as surgery, chemotherapy, hormone therapy, and immune therapy. The mechanism
                  of radiotherapy as a treatment for cancer is to damage the DNA of tumor cells. The
                  damage can directly or indirectly affect the DNA chain; more clearly, radiation can
                  directly affect DNA inside the cell and cause it to degrade or that radiation can cause
                  ionization of intracellular components and cause free radicals and thus indirectly
                  damages DNA (Fig. 4.4). On the other hand, this damage can be entered into a DNA
                  strand or entered into two strands of DNA. And since the cells have a mechanism
                  for repairing single strand DNA breaks (SSDB), it has been seen that double strand
                  DNA breaks (DSDB) is the most important technique that results in cell death [26].
                     Radiotherapy as a treatment for cancer induces different types of cell death.
                  Apoptosis and mitotic cell death or mitotic catastrophe are the major cell deaths
                  which happens after radiotherapy. In addition, radiation may cause other types of
   76   77   78   79   80   81   82   83   84   85   86